Hit enter to search or ESC to close
Home
About
Company Overview
Our Partners
Leadership Team
Board of Directors
Scientific Advisory Board
Pipeline
Pipeline of Compositions
Expansion Repeat Disorders
Myotonic Dystrophy Type 1
Myotonic Dystrophy Type 2
Platform
Overview
Publications
Newsroom
Contact
General Inquiries
Partnership Inquiries
Career Opportunities
News Alerts
DM1
In the News
Expanding Small Molecule Horizons – BioCentury
By
Expansion Therapeutics
January 4, 2018
January 5th, 2018
No Comments
Expanding Small Molecule Horizons – BioCentury
Love
0
Share
Tweet
Share
Home
About
Company Overview
Our Partners
Leadership Team
Board of Directors
Scientific Advisory Board
Pipeline
Pipeline of Compositions
Expansion Repeat Disorders
Myotonic Dystrophy Type 1
Myotonic Dystrophy Type 2
Platform
Overview
Publications
Newsroom
Contact
General Inquiries
Partnership Inquiries
Career Opportunities
News Alerts
Recent News and Insights
Perspectives on Targeting RNA with Small Molecules to Capture Opportunities at the Intersection of Chemistry, Biology, and Medicine – JACS
March 22, 2019
Expansion into TNBC – BioCentury
February 21, 2019
Expansion Therapeutics Names Elliot Ehrich, M.D., Chief Medical Officer
November 13, 2018
